Therapy Areas: Vaccines
Argentina will receive four million doses of AstraZeneca's COVID-19 vaccines this month
12 May 2021 -

The government of Argentina stated on Tuesday that the country is to receive four million doses of British pharmaceutical company AstraZeneca Plc's (LON:AZN) COVID-19 vaccine in May 2021, Reuters news agency reported on Wednesday.

This comes after long delays to a deal struck late last year by the government.

Argentina, which is currently facing a severe second wave of COVID-19 infections, has vaccinated 9.2 million people so far out of a total population of close to 45 million. Only 1.4 million have received the full two doses.

These vaccines are part of a deal Argentina struck in November 2020 for some 22.4 million doses of the vaccine developed by AstraZeneca and the University of Oxford.

Reportedly, these vaccines were meant to be produced regionally by Argentine firm mAbxience and Mexican laboratory Liomont. The latter has faced production delays.

Also, Argentina expects to receive 861,600 doses of AstraZeneca's vaccine this month through the COVAX programme backed by the World Health Organisation.

The country has reported over 3.16 million cases of COVID-19 and 67,821 deaths linked to the virus.